Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

NCT00365781 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ionis Pharmaceuticals, Inc.